SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030663
Filing Date
2021-07-29
Accepted
2021-07-29 18:04:31
Documents
2
Period of Report
2021-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8707
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3490
  Complete submission text file 0000899243-21-030663.txt   13608
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address
Pieper Steven (Reporting) CIK: 0001875714 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38536 | Film No.: 211129057